Qfin Holdings, Inc. (QFIN): what the price assumes

boothcheck covers Qfin Holdings, Inc. (QFIN) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-06-28.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/QFIN

Headline

FieldValue
TickerQFIN
CompanyQfin Holdings, Inc.
Current price$13.12/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfee-financial
Price-to-earnings1.9x
Earnings yield53.5%

The price sits below what even a 5%/yr fee-earnings decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 11.2% cost of equity with 4% terminal growth over a 5-year stage, on a 5-year median GAAP earnings base.

How unusual the bet is: within-range

ReferenceValue
vs own history-0.96σ
cohort percentile (of 51 peers)0
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.15x4justifies
Earnings0.19x1justifies
Relative0
Growth0.38x1justifies

Families that justify the price: Asset, Earnings, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.6%); the inversion above states its own rate.

Per-Model Detail (n=6)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthnoFCF base $1.6B, growth 2% (input: historical growth), terminal g 1.7%, WACC 8.6%, 5yr projection
DCF Exit MultipleGrowthnoExit EV/EBITDA: 4.0x / 1.2x / 3.2x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelativenoP/E 11.55x (blended: static sector reference 18x + trailing (TTM) 2x), scenarios: 9.7x / 11.6x / 13.4x (bear / base = reference held flat / bull), EV/EBITDA 7.68x
Simple DDMGrowthno
Two-Stage DDMGrowth$34.890.38xyesStage 1: 8% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$75.780.17xyesBV/sh $28.29, ROE (TTM) 24.8%, ke 9.3%
Two-Stage Excess ReturnAsset$124.560.11xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowthnoRev $2.7B, growth 2% (input: historical growth; tapered), Terminal P/S: 0.5x / 0.6x / 0.7x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelativenoEPS $6.30, growth 8% (input: historical EPS growth), PEG=0.24 (Undervalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarningsnoNormalized EBIT (5y avg op income, one-time charges added back) $0.88B × (1−19%) / WACC 8.6% → EPV (no growth)
Residual IncomeAsset$111.810.12xyesBV $28.29 + 5yr PV of (ROE (TTM) 24.8% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$63.320.21xyes√(22.5 × EPS $6.30 × BVPS $28.29) — Graham's conservative floor
EV/EBITDA RelativeRelativenoEBITDA $0.96B × sector EV/EBITDA 12.0x
FCF YieldEarningsnoFCF $1550.6M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsnoSBC-adj FCF $1.50B (FCF $1.55B − SBC $0.05B) capitalized at Kₑ
Ben Graham FormulaEarningsnoEPS $6.30 × (8.5 + 2×7.7%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetnoBV $28.29 × (ROIC 25.7% / WACC 8.6%)
P/Sales SectorRelativenoRevenue $2.75B × sector P/S 2.5x
PEG Fair ValueRelativenoEPS $6.30 × (PEG 1.5 × growth 7.7% (input: historical EPS growth)) → PE 11.6x
Earnings YieldEarnings$68.110.19xyesEPS $6.30 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net cash$535.4m
Net debt / NOPAT (after-tax)-0.69x (net cash)
Net debt / operating income (pre-tax)-0.56x (net cash)
Share count CAGR (buyback)-4.1%
Burning cashno

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

At $15.20 the stock trades near 4 times earnings, a roughly 23% earnings yield. Read as a capital-light fee business, the price sits below what even a 5%-a-year decline in fee earnings would justify. The multiple is pricing deterioration, not stability.

That deterioration is real and recent. First-quarter 2026 loan facilitation volume fell about 27% year over year, and management has guided to a 51% to 53% drop in net income, with lower lending rates squeezing the take rate. A cheap multiple on a falling earnings base is not the same as a cheap business.

The offset is capital return. The company carries net cash of about $535 million, announced a $450 million buyback, pays a double-digit dividend yield, and has shrunk its share count. The question the price poses is whether the cash coming back to shareholders outruns the regulatory pressure on the earnings stream funding it.

Bull Case

What the standard valuation models miss here is the gap between an accounting picture and a political one. On the numbers, Qfin looks absurdly cheap: trailing return on equity near 25%, earnings per share around $3.15, free cash flow near $1.55 billion, and net cash of roughly $535 million against a $15.20 price (June 28, 2026). Nearly every method in the screen lands far above the price. Earnings power value sits near $31, the Graham number near $30, residual income near $50, and even the conservative discounted-future-market-cap method at $11 is within shouting distance. A US-domiciled fee platform with these economics would not trade at 4 times earnings. The discount is the market's price for being a Chinese consumer-credit-tech company under a regulator that can change the rules.

The part the discount understates is the capital return. This is a capital-light business that converts earnings to cash and is sending that cash back aggressively. The company announced a $450 million buyback, pays a dividend that yields in the double digits, and has been reducing its share count, with a five-year share decline running around 4% a year. With net cash on the balance sheet and free cash flow comfortably covering both the buyback and the dividend, the shareholder yield is not financed by leverage or by raiding the business. A stock bought back at 4 times earnings is one of the few situations where repurchases are genuinely accretive rather than a way to mop up dilution.

The inversion frames the asymmetry cleanly. At about 4 times earnings the price is not asking for growth at all; it is below what even a steady 5%-a-year decline in fee earnings would warrant. That is a bound, not a forecast: the market is pricing the franchise to shrink. For the bull, the bet is simply that the business does not collapse, that loan facilitation stabilizes at a lower but profitable level, and that the cash keeps coming back. At this multiple the holder is paid to wait, and does not need the earnings to grow to make the math work.

Bear Case

The honest read on the model disagreement is that the conservative methods are telling the truth and the optimistic ones are extrapolating a past that is ending. The growth-anchored DCF lands near $94 only because it projects historical growth forward; the methods that price the business on what it is becoming, the exit-multiple DCF at $36, relative valuation at $35, and the discounted-future-market-cap at $11, sit much closer to the actual price. When the cheap-looking gap between price and fair value is built on backward-looking earnings, the gap is a warning, not an opportunity.

The earnings base is contracting, and the contraction is policy-driven. First-quarter 2026 total loan facilitation and origination volume fell about 27% year over year to roughly RMB 65 billion, and the prior quarter was already down about 22%. Management has forecast a year-over-year net income decline of 51% to 53% and has signaled that guidance to reduce overall lending rates will keep pressuring both volume and the net take rate. BofA Securities downgraded the stock in May 2026, cited prolonged regulatory headwinds, cut its 2026 to 2027 earnings estimates by more than half, and reduced its price target by 68% to $13.80. When a sell-side desk halves its estimates and an issuer guides earnings down by more than half in the same window, the 4-times multiple stops looking like a bargain and starts looking like a market that has done the arithmetic.

The structural truth a holder must face is that this is a Chinese consumer-lending platform whose unit economics are set, in part, by a regulator that has repeatedly compressed rates and volumes across the sector. The capital return is real, but a $450 million buyback and a high dividend are funded by an earnings stream the same regulator is squeezing. If facilitation volume keeps falling and the take rate keeps compressing, the cash available to return shrinks with it, and the double-digit yield that anchors the bull case re-rates the moment the payout has to be cut. A cheap multiple on a declining, policy-exposed earnings base is the textbook shape of a value trap, and the burden is on the business to prove the decline has a floor.

Valuation

A capital-light fee business is worth the fee earnings it throws off, not its book value, so the right lens is price-to-earnings. At $15.20 the stock trades near 4 times earnings, a roughly 23% earnings yield. Inverted, the price sits below what even a 5%-a-year decline in fee earnings would warrant, computed at an 11.1% cost of equity with 4% terminal growth on a five-year median earnings base. That is a bound rather than a solved point: the market is paying for the franchise to shrink, not to grow.

The method spread is unusually wide, and the spread itself is the information. The forward-growth perpetual DCF lands near $94, residual income near $50, simple excess return near $34, earnings power value near $31, and relative valuation near $35, while the discounted-future-market-cap method lands at $11. The blended central estimate that survives the screen is about $36, more than double the price. The model's reasonable-value band runs from roughly $64 at the low to $87 at the base. On the printed numbers the stock is deeply discounted on every family of method.

The reconciliation is the whole story. Those fair values are computed on a trailing earnings base that is now falling: loan volume down about 27% and management guiding net income down more than half. The methods are not wrong about the past; they are anchored to a level the business is leaving behind. The balance sheet is genuinely sound, net cash near $535 million with liquid assets above $1 billion, so this is not a solvency question. It is an earnings-durability question, and until the volume decline finds a floor the conservative methods, not the growth-extrapolating ones, are the honest read of what the price is worth.

Catalysts

The near-term catalysts run in both directions. On the negative side, first-quarter 2026 loan facilitation volume fell about 27% year over year to roughly RMB 65 billion, management guided to a 51% to 53% net income decline, and BofA Securities downgraded the stock in May 2026, cutting estimates by more than half and lowering its price target 68% to $13.80 on prolonged regulatory headwinds. The next quarterly print, and specifically whether loan volume and the net take rate stabilize, is the single most important catalyst for the thesis.

On the positive side, the company announced a $450 million buyback and continues to pay a dividend yielding in the double digits, backed by net cash of about $535 million and a sixth consecutive year of dividend payments. At a 4-times-earnings multiple, continued execution on repurchases is materially accretive, so the pace and size of buybacks each quarter is a catalyst worth tracking.

The overarching swing factor is Chinese regulatory policy on consumer lending rates and volumes. Management has indicated that guidance to reduce overall lending rates will likely keep pressuring loan volume and take rate, so any stabilization, or further tightening, of that policy is what ultimately decides whether the cheap multiple is a trap or an opportunity.

Sources: Qfin Holdings Q1 2026 results and earnings call (investing.com, sec.gov 6-K filings), BofA Securities downgrade (May 2026), stockanalysis.com.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive QFIN report on boothcheck